These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 34012070)

  • 1. Privacy practices using genetic data from cell-free DNA aneuploidy screening.
    Parobek CM; Russo ML; Lewkowitz AK
    Genet Med; 2021 Sep; 23(9):1746-1752. PubMed ID: 34012070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Privacy Risks in Prenatal Aneuploidy and Carrier Screening: What Obstetricians and Their Patients Need to Know.
    Parobek CM; Russo ML; Lewkowitz AK
    Obstet Gynecol; 2021 Jun; 137(6):1074-1079. PubMed ID: 33957653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Video education about genetic privacy and patient perspectives about sharing prenatal genetic data: a randomized trial.
    Parobek CM; Thorsen MM; Has P; Lorenzi P; Clark MA; Russo ML; Lewkowitz AK
    Am J Obstet Gynecol; 2022 Jul; 227(1):87.e1-87.e13. PubMed ID: 35351406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementation of cell-free DNA-based non-invasive prenatal testing in a National Health Service Regional Genetics Laboratory.
    Togneri FS; Kilby MD; Young E; Court S; Williams D; Griffiths MJ; Allen SK
    Genet Res (Camb); 2019 Dec; 101():e11. PubMed ID: 31813398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. State-wide utilization and performance of traditional and cell-free DNA-based prenatal testing pathways: the Victorian Perinatal Record Linkage (PeRL) study.
    Lindquist A; Hui L; Poulton A; Kluckow E; Hutchinson B; Pertile MD; Bonacquisto L; Gugasyan L; Kulkarni A; Harraway J; Howden A; McCoy R; Da Silva Costa F; Menezes M; Palma-Dias R; Nisbet D; Martin N; Bethune M; Poulakis Z; Halliday J
    Ultrasound Obstet Gynecol; 2020 Aug; 56(2):215-224. PubMed ID: 31625225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical utility of DNA-based screening for fetal aneuploidy by primary obstetrical care providers in the general pregnancy population.
    Palomaki GE; Kloza EM; O'Brien BM; Eklund EE; Lambert-Messerlian GM
    Genet Med; 2017 Jul; 19(7):778-786. PubMed ID: 28079901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Practice Guidelines for Prenatal Aneuploidy Screening and Diagnostic Testing from Korean Society of Maternal-Fetal Medicine: (1) Prenatal Aneuploidy Screening.
    Choe SA; Seol HJ; Kwon JY; Park CW; Kim M; Lee JY; Kim MA; Hwang HS; Na S; Shim JY; Kim K; Ryu HM
    J Korean Med Sci; 2021 Jan; 36(4):e27. PubMed ID: 33496086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The personal utility of cfDNA screening: Pregnant patients' experiences with cfDNA screening and views on expanded cfDNA panels.
    Farrell RM; Agatisa PK; Michie MM; Greene A; Ford PJ
    J Genet Couns; 2020 Feb; 29(1):88-96. PubMed ID: 31680382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of patient education materials: the example of circulating cell free DNA testing for aneuploidy.
    Kloza EM; Haddow PK; Halliday JV; O'Brien BM; Lambert-Messerlian GM; Palomaki GE
    J Genet Couns; 2015 Apr; 24(2):259-66. PubMed ID: 25204423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prenatal cell-free DNA screening for fetal aneuploidy in pregnant women at average or high risk: Results from a large US clinical laboratory.
    Guy C; Haji-Sheikhi F; Rowland CM; Anderson B; Owen R; Lacbawan FL; Alagia DP
    Mol Genet Genomic Med; 2019 Mar; 7(3):e545. PubMed ID: 30706702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA sequencing versus standard prenatal aneuploidy screening.
    Bianchi DW; Parker RL; Wentworth J; Madankumar R; Saffer C; Das AF; Craig JA; Chudova DI; Devers PL; Jones KW; Oliver K; Rava RP; Sehnert AJ;
    N Engl J Med; 2014 Feb; 370(9):799-808. PubMed ID: 24571752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noninvasive prenatal screening for fetal aneuploidy, 2016 update: a position statement of the American College of Medical Genetics and Genomics.
    Gregg AR; Skotko BG; Benkendorf JL; Monaghan KG; Bajaj K; Best RG; Klugman S; Watson MS
    Genet Med; 2016 Oct; 18(10):1056-65. PubMed ID: 27467454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PREIMPLANTATION GENETIC TESTING: Non-invasive prenatal testing for aneuploidy, copy-number variants and single-gene disorders.
    Shaw J; Scotchman E; Chandler N; Chitty LS
    Reproduction; 2020 Nov; 160(5):A1-A11. PubMed ID: 32130205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal plasma genome-wide cell-free DNA can detect fetal aneuploidy in early and recurrent pregnancy loss and can be used to direct further workup.
    Yaron Y; Pauta M; Badenas C; Soler A; Borobio V; Illanes C; Paz-Y-Miño F; Martinez-Portilla R; Borrell A
    Hum Reprod; 2020 May; 35(5):1222-1229. PubMed ID: 32386059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethical Aspects of Prenatal DNA Testing.
    Stanić Ž; Hrgović Z; Fureš R; Vusić I; Lagančić M
    Z Geburtshilfe Neonatol; 2022 Oct; 226(5):300-303. PubMed ID: 36037825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-Free DNA Screening for Single-Gene Disorders.
    Goodhue BS; Danity SE; Vora N; Kuller JA; Grace MR
    Obstet Gynecol Surv; 2024 Mar; 79(3):176-181. PubMed ID: 38482747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-free DNA for the detection of fetal aneuploidy.
    Goldwaser T; Klugman S
    Fertil Steril; 2018 Feb; 109(2):195-200. PubMed ID: 29447662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Innovative Prenatal Testing: Clinical Applications and Ethical Considerations].
    Huang MC; Lin SJ; Chen CL; Huang TJ
    Hu Li Za Zhi; 2017 Oct; 64(5):5-10. PubMed ID: 28948585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Informed decision-making about prenatal cfDNA screening: An assessment of written materials.
    Michie M; Kraft SA; Minear MA; Ryan RR; Allyse MA
    Ethics Med Public Health; 2016; 2(3):362-371. PubMed ID: 27699200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.